207 related articles for article (PubMed ID: 17804176)
1. Fibrosis in Hodgkin and non-Hodgkin lymphomas.
Tataroglu C; Sarioglu S; Kargi A; Ozkal S; Aydin O
Pathol Res Pract; 2007; 203(10):725-30. PubMed ID: 17804176
[TBL] [Abstract][Full Text] [Related]
2. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
3. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
4. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
Fukushima H; Ohsawa M; Ikura Y; Naruko T; Sugama Y; Suekane T; Kitabayashi C; Inoue T; Hino M; Ueda M
Histopathology; 2006 Nov; 49(5):498-505. PubMed ID: 17064296
[TBL] [Abstract][Full Text] [Related]
5. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
[TBL] [Abstract][Full Text] [Related]
6. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
8. [Borderline between Hodgkin and non-Hodgkin lymphomas with unfavorable clinical course: a clinical, histological and immunohistochemical analysis of 33 cases within the German Hodgkin Lymphoma Study].
Bernhards J; Fischer R; Werner M; Hübner K; Schwarze EW; Georgii A
Verh Dtsch Ges Pathol; 1992; 76():159-63. PubMed ID: 1283250
[TBL] [Abstract][Full Text] [Related]
9. Mast cell reactivity in lymphoma: a preliminary communication.
Sharma VK; Agrawal A; Pratap VK; Nagar AM; Mehrotra ML
Indian J Cancer; 1992 Jun; 29(2):61-5. PubMed ID: 1473834
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
11. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.
Hedström G; Berglund M; Molin D; Fischer M; Nilsson G; Thunberg U; Book M; Sundström C; Rosenquist R; Roos G; Erlanson M; Amini RM; Enblad G
Br J Haematol; 2007 Jul; 138(1):68-71. PubMed ID: 17555448
[TBL] [Abstract][Full Text] [Related]
12. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
[TBL] [Abstract][Full Text] [Related]
13. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
14. Mast cells contribute to the angiogenesis in non-Hodgkin lymphoma. An immunohistochemical study based on the relationship with microvessel density.
Duşe AO; Ceauşu RA; Mezei T; Cîmpean AM; Gaje P; Ioniţă H; Jung I
Rom J Morphol Embryol; 2011; 52(3 Suppl):1091-6. PubMed ID: 22119830
[TBL] [Abstract][Full Text] [Related]
15. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
16. Sclerosis in non-Hodgkin's lymphomata.
Bennett MH
Br J Cancer Suppl; 1975 Mar; 2():44-52. PubMed ID: 1101930
[TBL] [Abstract][Full Text] [Related]
17. Quantitative digital histochemistry with methenamine silver staining in renal allograft biopsies excluding pure chronic allograft nephropathy cases.
Sarioglu S; Sis B; Celik A; Tekis D; Kavukcu S; Bora S; Camsari T
Transplant Proc; 2006 Mar; 38(2):490-1. PubMed ID: 16549156
[TBL] [Abstract][Full Text] [Related]
18. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
[TBL] [Abstract][Full Text] [Related]
19. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma.
Glimelius I; Edström A; Amini RM; Fischer M; Nilsson G; Sundström C; Enblad G; Molin D
Eur J Haematol; 2006 Apr; 76(4):278-83. PubMed ID: 16519698
[TBL] [Abstract][Full Text] [Related]
20. Expression of mast cell tryptases in Hodgkin and Reed-Sternberg (HRS) cells.
Carvalho RF; Mahshid Y; Claesson HE; Glimelius I; Fischer M; Nilsson G
Scand J Immunol; 2008 Jan; 67(1):53-6. PubMed ID: 18021188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
